|
hal-01503616v1
Journal articles
Emilie Cornec-Le Gall, Marie-Pierre Audrézet, Eric Renaudineau, Maryvonne Hourmant, Christophe Charasse et al. PKD2-Related Autosomal Dominant Polycystic Kidney Disease: Prevalence, Clinical Presentation, Mutation Spectrum, and Prognosis.American Journal of Kidney Diseases, Elsevier, 2017, 70 (4), pp.476-485. ⟨10.1053/j.ajkd.2017.01.046⟩
|
|
|
|
|
|
|
|
|
|
|
|
hal-01320719v1
Journal articles
Béatrice Delasalle, Jean-Marc Davy, Antoine Leenhardt, Salem Kacet, Pascal Defaye et al. 0332 : QUIDAM Study: assessment of hydroquinidine therapy in the management of Brugada syndrome patients at high arrhythmic risk and implanted with an ICDArchives of Cardiovascular Diseases Supplements, Elsevier/French Society of Cardiology, 2016, Printemps de la Cardiologie : Recherche Fondamentale et Clinique - Centre de Congrès Dijon, 7-8 avril 2016, 8 (3), pp.225--226. ⟨10.1016/S1878-6480(16)30422-0⟩
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
hal-03469322v1
Journal articles
C. Esnault, V. Leblond, C. Martin, A. Desgranges, C.B. Baltus et al. Adcitmer ® , a new CD56‐targeting monomethyl auristatin E‐conjugated antibody, is a potential therapeutic approach in Merkel cell carcinomaBritish Journal of Dermatology, Wiley, 2022, 186 (2), pp.295-306. ⟨10.1111/bjd.20770⟩
|
|
|
|
|
|
|
|
|
|
|
|
|